Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Central Garden & Pet Co. Reports Decline in Q1 Net Sales

Central Garden & Pet Co. has recently released its 10-Q report, revealing a decline in net sales and operating income for the first quarter of fiscal 2026. The company operates through two segments: Pet and Garden, offering a wide range of products for the lawn and garden, and pet supplies markets. In fiscal 2025, the company reported consolidated net sales of $3.1 billion, with the Pet segment accounting for approximately $1.8 billion and the Garden segment accounting for approximately $1.3 billion.

However, in the first quarter of fiscal 2026, Central Garden & Pet Co. experienced a 6.0% decrease in net sales, amounting to $617 million, compared to the prior year quarter. The Pet segment's net sales decreased by 2.7%, while the Garden segment saw a larger decline of 12.0%. This led to a 2.6% decrease in gross profit, although the gross margin increased by 110 basis points to 30.9%.

Selling, general, and administrative expenses increased by 3.8% to $174.1 million, accounting for 28.2% of net sales. As a result, the operating income declined by 40.9% to $16.5 million in the first quarter of fiscal 2026. The company reported a net income of $6.8 million, or $0.11 per diluted share, compared to $14.0 million, or $0.21 per diluted share, in the first quarter of fiscal 2025.

In December 2025, Central Garden & Pet Co. acquired the U.S. assets of Champion USA LLC for approximately $57 million, strengthening its position in the livestock industry. The company also incurred approximately $7.7 million in charges related to facility closures as part of its Cost and Simplicity program aimed at achieving a more efficient manufacturing and logistics network.

As a result of these announcements, the company's shares have moved -2.98% on the market, and are now trading at a price of $32.25. If you want to know more, read the company's complete 10-Q report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS